UroGen Pharma Ltd. clinical trial pipeline

2 trials changed in the last 30 days: 0 stopped, 2 with notable changes, 0 with minor changes only.

1. Notable

   uTRACT · Jelmyto Registry: A Registry · Upper Tract Urothelial…uTRACT · Jelmyto Registry: A Registry · Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto

   Primary completion pushed from Apr 2026 to Oct 2027

   Also in this update: Primary endpoint(s) modified; Enrollment increased: 400 → 450 participants

   UroGen Pharma Ltd.·Not specified· NCT05874921· Registry history of NCT05874921 on ClinicalTrials.gov (opens the registry)

   Sep 29, 2026

2. Notable

   UTOPIA · UGN-103 · Low-grade Intermediate-risk Non-muscle…UTOPIA · UGN-103 · Low-grade Intermediate-risk Non-muscle Invasive Bladder Cancer

   Results posted: Sep 28, 2026

   UroGen Pharma Ltd.·Phase 3· NCT06331299· Registry history of NCT06331299 on ClinicalTrials.gov (opens the registry)

   Sep 28, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.